- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor ; volume:5 ; number:1 ; day:13 ; month:3 ; year:2007 ; pages:1-12 ; date:12.2007
Journal of translational medicine ; 5, Heft 1 (13.3.2007), 1-12, 12.2007
- Creator
- Contributor
-
van den Engel, Natasja K.
Poehlein, Christian H.
Hatz, Rudolf A.
Fox, Bernard A.
Hu, Hong-Ming
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-5-14
- URN
-
urn:nbn:de:1111-2016041431810
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Winter, Hauke
- van den Engel, Natasja K.
- Poehlein, Christian H.
- Hatz, Rudolf A.
- Fox, Bernard A.
- Hu, Hong-Ming
- SpringerLink (Online service)
Other Objects (12)
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation